Recombinant Human Bone Morphogenetic Protein-2 in Posterolateral Spinal Fusion: What's the Right Dose?

Study DesignSingle center retrospective cohort analysis.PurposeThe goal was to evaluate the influence of varying amount of recombinant human bone morphogenetic protein 2 (rhBMP-2) per level on fusion rates and complications in posterolateral spinal fusions.Overview of LiteraturerhBMP-2 has been util...

Full description

Bibliographic Details
Main Authors: Martin Franz Hoffmann, Clifford Barry Jones, Debra Lynn Sietsema
Format: Article
Language:English
Published: Korean Spine Society 2016-06-01
Series:Asian Spine Journal
Subjects:
Online Access:http://www.asianspinejournal.org/upload/pdf/asj-10-457.pdf